DE60202667D1 - Diazabicyclo [2.2.1] heptanderivate - Google Patents

Diazabicyclo [2.2.1] heptanderivate

Info

Publication number
DE60202667D1
DE60202667D1 DE60202667T DE60202667T DE60202667D1 DE 60202667 D1 DE60202667 D1 DE 60202667D1 DE 60202667 T DE60202667 T DE 60202667T DE 60202667 T DE60202667 T DE 60202667T DE 60202667 D1 DE60202667 D1 DE 60202667D1
Authority
DE
Germany
Prior art keywords
diseases
disorders
diazabicyclo
nervous system
disorders related
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60202667T
Other languages
English (en)
Other versions
DE60202667T2 (de
Inventor
Dan Peters
M Olsen
Elsebet Nielsen
K Ahring
Dyhring Jorgensen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NTG Nordic Transport Group AS
Original Assignee
Neurosearch AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch AS filed Critical Neurosearch AS
Publication of DE60202667D1 publication Critical patent/DE60202667D1/de
Application granted granted Critical
Publication of DE60202667T2 publication Critical patent/DE60202667T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE60202667T 2001-03-02 2002-02-28 Neue 2,5-diazabicyclo [2.2.1] heptanderivate Expired - Lifetime DE60202667T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK200100344 2001-03-02
DKPA200100344 2001-03-02
PCT/DK2002/000133 WO2002070522A1 (en) 2001-03-02 2002-02-28 Novel 2,5-diazabicyclo[2.2.1]heptane derivatives

Publications (2)

Publication Number Publication Date
DE60202667D1 true DE60202667D1 (de) 2005-02-24
DE60202667T2 DE60202667T2 (de) 2005-06-16

Family

ID=8160337

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60202667T Expired - Lifetime DE60202667T2 (de) 2001-03-02 2002-02-28 Neue 2,5-diazabicyclo [2.2.1] heptanderivate

Country Status (13)

Country Link
US (1) US7329754B2 (de)
EP (1) EP1368348B1 (de)
JP (1) JP4294958B2 (de)
CN (1) CN1331864C (de)
AT (1) ATE287404T1 (de)
AU (1) AU2002233181B2 (de)
CA (1) CA2438815A1 (de)
DE (1) DE60202667T2 (de)
DK (1) DK1368348T3 (de)
HK (1) HK1068878A1 (de)
MX (1) MXPA03007895A (de)
NZ (1) NZ527006A (de)
WO (1) WO2002070522A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2468015A1 (en) * 2001-11-27 2003-06-05 Merck & Co., Inc. 2-aminoquinoline compounds
BRPI0908807A2 (pt) * 2008-02-15 2015-07-28 Hoffmann La Roche Derivados de 3-alquil-piperazina e usos dos mesmos

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN166416B (de) * 1985-09-18 1990-05-05 Pfizer
US5196548A (en) 1989-05-11 1993-03-23 Pfizer Inc. Preparation of diazabicyclic Intermediates
JPH06228138A (ja) 1993-02-03 1994-08-16 Fujisawa Pharmaceut Co Ltd ピリドシンノリン化合物またはその塩及びこれを含有する抗菌剤
US5478939A (en) * 1994-07-20 1995-12-26 American Cyanamid Company (R,R) and (S,S) 2,5-diazabicyclo [2,2,1]heptane derivatives
US5561127A (en) 1994-12-19 1996-10-01 Allelix Biopharmaceuticals, Inc. Muscarinic receptor ligands
FR2786769B1 (fr) 1998-12-04 2002-10-25 Synthelabo Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique
EP1147112B1 (de) * 1999-01-29 2003-10-29 Abbott Laboratories Diazabicyloderivate als nikotin-acetylcholin-rezeptorliganden
PT1289996E (pt) 2000-05-25 2005-07-29 Targacept Inc Heteroarildiazabicicloalcanos como ligandos do receptor colinergico nicotinico
CA2354606C (en) 2000-08-03 2005-12-06 Pfizer Products Inc. Azabicycloalkane derivatives and therapeutic uses thereof

Also Published As

Publication number Publication date
DK1368348T3 (da) 2005-05-23
CA2438815A1 (en) 2002-09-12
EP1368348B1 (de) 2005-01-19
HK1068878A1 (en) 2005-05-06
US7329754B2 (en) 2008-02-12
EP1368348A1 (de) 2003-12-10
JP2004529901A (ja) 2004-09-30
NZ527006A (en) 2005-02-25
ATE287404T1 (de) 2005-02-15
US20040181069A1 (en) 2004-09-16
CN1331864C (zh) 2007-08-15
MXPA03007895A (es) 2003-12-04
AU2002233181B2 (en) 2007-06-07
CN1535273A (zh) 2004-10-06
JP4294958B2 (ja) 2009-07-15
DE60202667T2 (de) 2005-06-16
WO2002070522A1 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
IL166254A0 (en) Novel quinuclidine derivatives and their use
HK1068628A1 (en) Nicotinic acetyl-choline receptors inhibitor compounds, their preparation and use
PL375025A1 (en) Novel 1,4-diazabicycloalkane derivatives, their preparation and use
AU2002220517A1 (en) 3-substituted quinuclidines and their use as nicotinic agonists
HK1057550A1 (en) Aryl and heteroaryl diazabicycloalkanes, their preparation and use.
DK1506200T3 (da) Diazabicykliske biarylderivater
AU2003280309A1 (en) 1,4-diazabicyclo (3,2,2)nonane derivatives, preparation and therapeutical use thereof
ATE289310T1 (de) Heteroaryl-diazabicycloalkanderivaten als cns- modulatoren
ATE437880T1 (de) Dimere azacyclische verbindungen und deren verwendung
HK1079528A1 (en) Azacyclic ethynyl derivatives
MXPA05006861A (es) Derivados arildiazabiciclicos novedosos.
DE60307102D1 (de) 3-substituierte chinuklidine und deren verwendung
HK1068878A1 (en) Novel 2, 5-diazabicyclo Ä2.2.1Üheptane derivatives
DE602004031124D1 (de) Neue chinuklidinderivative und deren pharmazeutische verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition